About Spark Therapeutics
Spark Therapeutics is a company based in Philadelphia (United States) founded in 2013 was acquired by Roche in February 2019.. Spark Therapeutics has raised $82.8 million across 2 funding rounds from investors including Roche, Children's Hospital of Philadelphia and T. Rowe Price. The company has 822 employees as of December 31, 2021. Spark Therapeutics has completed 1 acquisition, including Genable Technologies. Spark Therapeutics operates in a competitive market with competitors including Moderna, BridgeBio, Alnylam, ATAI and Insitro, among others.
- Headquarter Philadelphia, United States
- Employees 822 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Spark Therapeutics, Inc.
-
Annual Revenue
$64.73 M436as on Dec 31, 2018
-
Net Profit
$-78.82 M69as on Dec 31, 2018
-
EBITDA
$-193.64 M25as on Dec 31, 2018
-
Total Equity Funding
$82.8 M (USD)
in 2 rounds
-
Latest Funding Round
$72.8 M (USD), Series B
May 23, 2014
-
Investors
Roche
& 7 more
-
Employee Count
822
as on Dec 31, 2021
- Investments & Acquisitions
-
Acquired by
Roche
(Feb 22, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
146 people
Software Development Team
120 people
Product Management Team
79 people
Senior Team
63 people
Sales and Marketing
48 people
Data Analysis and Operations Team
44 people
Principal Team
27 people
Legal and Compliance
26 people
Unlock access to complete
Funding Insights of Spark Therapeutics
Spark Therapeutics has successfully raised a total of $82.8M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $72.8 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $72.8M
-
First Round
First Round
(22 Oct 2013)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2014 | Amount | Series B - Spark Therapeutics | Valuation | Sofinnova Investments | |
| Oct, 2013 | Amount | Series A - Spark Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Spark Therapeutics
Spark Therapeutics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche, Children's Hospital of Philadelphia and T. Rowe Price. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spark Therapeutics
Spark Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Genable Technologies. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gene therapy for Retinitis pigmentosa is developed using AAV vectors.
|
2001 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Spark Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Spark Therapeutics Comparisons
Competitors of Spark Therapeutics
Spark Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Spark Therapeutics
Frequently Asked Questions about Spark Therapeutics
When was Spark Therapeutics founded?
Spark Therapeutics was founded in 2013.
Where is Spark Therapeutics located?
Spark Therapeutics is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Spark Therapeutics a funded company?
Spark Therapeutics is a funded company, having raised a total of $82.8M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Oct 22, 2013.
How many employees does Spark Therapeutics have?
As of Dec 31, 2021, the latest employee count at Spark Therapeutics is 822.
What is the annual revenue of Spark Therapeutics?
Annual revenue of Spark Therapeutics is $64.73M as on Dec 31, 2018.
What does Spark Therapeutics do?
Spark Therapeutics was founded in 2013 and is headquartered in Philadelphia, United States. Focus is placed on the biotechnology sector, where gene therapies for rare diseases are developed. Engineered adeno-associated viruses are used to deliver target gene sequences for treating RPE-65 mediated inherited retinal dystrophies, choroideremia, hemophilia A and B, and neurodegenerative conditions such as Battens disease. Operations center on advancing these therapies through research and clinical development.
Who are the top competitors of Spark Therapeutics?
How many acquisitions has Spark Therapeutics made?
Spark Therapeutics has made 1 acquisition, including Genable Technologies.
Who are Spark Therapeutics's investors?
Spark Therapeutics has 8 investors. Key investors include Roche, Children's Hospital of Philadelphia, T. Rowe Price, Sofinnova, and Brookside Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.